Direct and “end-payor” purchasers of the constipation drug Amitiza gained class status in a case accusing Takeda Pharmaceutical Co. Ltd. of delaying the generic form of the medication, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback